BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9261736)

  • 1. Expression of epidermal growth factor in gestational trophoblastic disease (GTD).
    John M; Rajalekshmy TN; Nair MB; Augustine J; Schultz G; Nair MK; Balaram P
    J Exp Clin Cancer Res; 1997 Jun; 16(2):129-34. PubMed ID: 9261736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epidermal growth factor and its receptor in gestational trophoblastic diseases.
    John M; Rajalekshmy T; Nair B; Augustine J; Schultz G; Nair K; Balaram P
    Oncol Rep; 1997; 4(1):177-82. PubMed ID: 21590037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of epidermal growth factor receptor in gestational trophoblastic diseases.
    Balaram P; John M; Rajalekshmy TN; Nair B; Schultz G; Nair K
    J Cancer Res Clin Oncol; 1997; 123(3):161-6. PubMed ID: 9119881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
    Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MMP-2/TIMP-2 expression in the trophoblasts of patients with gestational trophoblastic disease].
    Ding F; Zhang QS; Xing FQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):150-2. PubMed ID: 17355922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of TM4SF9 in human trophoblasts].
    Gao TY; Yu YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1080-2. PubMed ID: 18583270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology of human trophoblast.
    Mochizuki M; Maruo T; Matsuo H; Samoto T; Ishihara N
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S21-8. PubMed ID: 9833611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
    Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
    Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
    Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
    Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast.
    Crescimanno C; Marzioni D; Paradinas FJ; Schrurs B; Mühlhauser J; Todros T; Newlands E; David G; Castellucci M
    J Pathol; 1999 Dec; 189(4):600-8. PubMed ID: 10629564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of KiSS-1 and matrix metalloproteinase-9 in regulation of invasion of trophoblasts].
    Qiao C; Cheng DL; Zhang SL; Wang CH; Lin QD
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):839-42. PubMed ID: 15949403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating cell nuclear antigen (PCNA) expression in gestational trophoblastic diseases (GTD).
    Molykutty J; Rajalekshmy TN; Balaraman NM; Swapna E; Krishnan NM; Balaram P
    Neoplasma; 1998; 45(5):301-4. PubMed ID: 9921919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of c-erbB2 in gestational trophoblastic disease and its clinical significance.
    Wang Y; Cao Y; Sun Y
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(2):123-5. PubMed ID: 12658752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of laminin and laminin receptor in gestational trophoblastic tumor and its significance].
    An RF; Wang S; Zhang YA; Bai XQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):344-6, 350. PubMed ID: 15931864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta.
    Singh M; Kindelberger D; Nagymanyoki Z; Ng SW; Quick CM; Elias KM; Yamamoto H; Fichorova R; Fulop V; Berkowitz RS
    Gynecol Oncol; 2011 Jul; 122(1):178-82. PubMed ID: 21514631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the human P2Y6 nucleotide receptor in normal placenta and gestational trophoblastic disease.
    Somers GR; Bradbury R; Trute L; Conigrave A; Venter DJ
    Lab Invest; 1999 Feb; 79(2):131-9. PubMed ID: 10068202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.
    Fock V; Plessl K; Fuchs R; Dekan S; Milla SK; Haider S; Fiala C; Knöfler M; Pollheimer J
    Hum Reprod; 2015 Apr; 30(4):789-99. PubMed ID: 25740878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.